Market and Trading Information for Intellia Therapeutics
The following details were available for trading and market data about the stock of Intellia Therapeutics as of writing:
Trading Details of Intellia Therapeutics (NTLA)
Current Share Price:
$22.92
Previous Year's Closing Price:
$30.49
Percentage Price Change (YTD):
-24.83%
Market Cap:
$2.33 billion
52-week Price Range:
$22.51 - $47.48
Dividend Per Share:
$0
EPS (TTM):
-5.42
Price-Earnings (Trailing):
0
Price-Earnings (Forward):
-4.17
Company Profile and Business Description for Intellia Therapeutics
Intellia Therapeutics, Inc., incorporated on May 7, 2014, is a genome editing company. The Company is focused on developing therapeutics utilizing a biological tool known as CRISPR/Cas9. The CRISPR/Cas9 genome editing system includes two components: the Cas9 protein and the guide RNA sequence. Th...to see full details, pleaseLogin / Register to view.
ETFs Holding Intellia Therapeutics Stock
As of March 2020, the following exchange-traded funds (ETF) hold the Intellia Therapeutics stocks in their respective portfolios. Below is a random list of only 10 ETFs in no particular order that have Intellia Therapeutics stock holding. There are a total of 32 ETFs in Fknol.com records which are holding Intellia Therapeutics stock in their portfolio. See Full List.
The ARK Innovation ETF is an actively managed fund that targets companies poised to benefit from disruptive innovation in one of three areas: industrial innovation, genomics or Web x.0. ...Full Details
AVUS is an actively managed diverse portfolio of U.S. large-, mid-, and small-cap stocks aiming to find those with lower price relative to valuations. ...Full Details
The iShares NASDAQ Biotechnology ETF tracks the performance of a market-cap-weighted index of biotechnology and pharmaceutical companies listed on the NASDAQ. ...Full Details ...Candlestick Patterns.
The iShares Genomics Immunology and Healthcare ETF tracks a market-cap selected and weighted index of global stocks involved in genomics, immunology, and bioengineering. ...Full Details
The iShares Core S&P Total U.S. Stock Market ETF tracks a market cap-weighted index of all common equities listed on the NYSE and the NASDAQ. ...Full Details
See Full List of ETFs holding Intellia Therapeutics stock in their respective portfolios.
U.S. Stock Screener:
Peer / Competitor Companies of Biotech In Vitro In Vivo Diagnostics Sector
Along with Intellia Therapeutics, Inc., the following other peer (competitor) companies also exist within the same Biotech In Vitro In Vivo Diagnostics - Healthcare sector whose company profile and dividend history is as follows:
▶ Akers Biosciences (AKER): Akers Biosciences, Inc., incorporated on March 9, 1989, develops, manufactures and supplies point-of-care screening and testing products designed to bring health-related information to the patient or clinician. The Companys product ....See Detailed Company Profile, Dividend History
▶ ARCA biopharma (ABIO): ARCA biopharma, Inc. (ARCA), incorporated on March 16, 2004, is a biopharmaceutical company. The Company is principally focused on developing genetically-targeted therapies for cardiovascular diseases. The Companys lead product candidate ....See Detailed Company Profile, Dividend History
▶ Celldex Therapeutics (CLDX): Celldex Therapeutics, Inc., incorporated on December 9, 1983, is a biopharmaceutical company. The Company is focused on the development and commercialization of several immunotherapy technologies for the treatment of cancer ....See Detailed Company Profile, Dividend History
▶ IDEXX Laboratories (IDXX): IDEXX Laboratories, Inc., incorporated on December 19, 1983, develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, dairy and water testing markets. ....See Detailed Company Profile, Dividend History
▶ ImmuCell (ICCC): ImmuCell Corporation, incorporated on February 9, 1987, is an animal health company. The Company operates in the development, acquisition, manufacture and sale of products that improve the health and productivity ....See Detailed Company Profile, Dividend History
▶ Immunomedics (IMMU): Immunomedics, Inc., incorporated on July 6, 1982, is a clinical-stage biopharmaceutical company, which is engaged in researching, developing, manufacturing and marketing biopharmaceutical products. It develops monoclonal antibody-based products for the ....See Detailed Company Profile, Dividend History
▶ Lantheus (LNTH): Lantheus Holdings, Inc., incorporated on November 30, 2007, is engaged in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and ....See Detailed Company Profile, Dividend History
▶ Meridian Bioscience (VIVO): Meridian Bioscience, Inc., incorporated on June 25, 1976, is a life science company. The Company is engaged in the development, manufacture, sale and distribution of diagnostic test kits for gastrointestinal, ....See Detailed Company Profile, Dividend History
▶ Myriad Genetics (MYGN): Myriad Genetics, Inc. (Myriad), incorporated on November 6, 1992, is a molecular diagnostic company. The Company is engaged in the discovery, development and marketing of transformative molecular diagnostic tests. The ....See Detailed Company Profile, Dividend History
▶ Navidea BioPharma (NAVB): Navidea Biopharmaceuticals, Inc. (Navidea), incorporated on April 28, 1988, is a biopharmaceutical company focused on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. The Company is developing multiple ....See Detailed Company Profile, Dividend History
▶ Neogen (NEOG): Neogen Corporation, incorporated on June 30, 1981, develops, manufactures and markets a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food ....See Detailed Company Profile, Dividend History
▶ Nymox Pharmaceutical (NYMX): Nymox Pharmaceutical Corp is a Canada-based biopharmaceutical company. The Company is focused on developing its drug candidate, NX-1207, for the treatment of benign prostatic hyperplasia (BPH) and the treatment of ....See Detailed Company Profile, Dividend History
▶ OncoCyte (OCX): OncoCyte Corporation (OncoCyte), incorporated on September 30, 2009, is a development-stage biotechnology company focused in the field of regenerative medicine. The Company is developing molecular cancer diagnostics utilizing a discovery ....See Detailed Company Profile, Dividend History
▶ Oxford Immunotec Global (OXFD): Oxford Immunotec Global PLC, incorporated on August 16, 2013, is a diagnostics company. The Company is focused on developing and commercializing tests for under-served immune-regulated conditions. The Companys product lines ....See Detailed Company Profile, Dividend History
▶ Quidel (QDEL): Quidel Corporation, incorporated on July 14, 1987, is engaged in the development, manufacturing and marketing of diagnostic testing solutions. These diagnostic testing solutions are separated into four product categories: immunoassays, ....See Detailed Company Profile, Dividend History
▶ Quotient (QTNT): Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, and commercializes conventional reagent products used for blood grouping in the transfusion diagnostics market worldwi....See Detailed Company Profile, Dividend History
▶ Trinity Biotech (TRIB): Trinity Biotech plc (Trinity Biotech), incorporated on January 22, 1992, develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market. ....See Detailed Company Profile, Dividend History
▶ Vermillion (VRML): Vermillion, Inc., incorporated on May 23, 2000, is a diagnostic service and bio-analytic solutions provider. The Company is engaged in the business of developing and commercializing diagnostic tests for gynecologic ....See Detailed Company Profile, Dividend History
▶ VolitionRX (VNRX): VolitionRx Limited, incorporated on September 24, 1998, is a clinical-stage life sciences company. The Company is focused on developing blood-based diagnostic tests for detecting and diagnosing cancer and other diseases. ....See Detailed Company Profile, Dividend History